Picton Mahoney Asset Management Ani Pharmaceuticals Inc Transaction History
Picton Mahoney Asset Management
- $4.9 Billion
- Q4 2024
A detailed history of Picton Mahoney Asset Management transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Picton Mahoney Asset Management holds 20 shares of ANIP stock, worth $1,352. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20Holding current value
$1,352% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANIP
# of Institutions
213Shares Held
19.3MCall Options Held
3.4KPut Options Held
10.8K-
Black Rock Inc. New York, NY2.66MShares$180 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$88.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1MShares$67.8 Million0.03% of portfolio
-
State Street Corp Boston, MA737KShares$49.8 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY700KShares$47.3 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.18B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...